Your selection
Research, Innovation, Patient care, Education / 18.09.2025
Talk in the Cube: IP STRATEGIES IN BIOTECHNOLOGY
We are excited to continue the Talks in the Cube with an expert discussion focused on Strategies for Intellectual Property Rights in Biotechnology.
Effective strategies for Intellectual Property (IP) in Biotechnology include using patents for new processes and products, applying trade secrets for complex bioengineering methods, and employing trademarks for branding. A comprehensive strategy also means building adequate patent portfolios through patent jungles or "Biobetters", monitoring and defending IP rights against infringement, and potentially using licensing agreements for technology transfer.
Our two esteemed experts who are trained natural scientists AND European Patent Attorneys. They will share their insights and experiences with us.
A Panel Discussion with
Dr. Sun Jin Lee, European Patent Attorney, European Patent Litigator (UPC), Maiwald GmbH, Munich
Dr. Oliver Ladendorf, LL.B., European Patent Attorney, Kraus & Lederer PartGmbH, Munich
Dr. Uwe Lohmeier, Berlin BioScience Academy (BBA), Campus Berlin Buch GmbH (Moderation).
Topics planned to be addressed
- Smart patenting for Biotech: Portfolios providing leverage and attracting investors
- Licensing of innovative technologies: Patents for organoids and CRISPR/Cas
- Biotech Patents and AI: Examples to influence innovations and to protect data-driven discoveries.
The talk will be followed by a networking event where you can socialize over snacks and drinks.
Target audience
Founders & scientists from start-ups, small and medium-sized life science companies and scientific institutions.
Costs
Participation is free of charge. Registration is requested.
When
Thursday, 18 September 2025
5:00 p.m. - 7:00 p.m.
Where
BerlinBioCube (Building D95), Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin
Quelle: BerlinBioscience Academy
Further information and registration
Overview News
News Buch Berlin
“The coolest part is vortexing”
One week, two topics, and plenty of new experiences: 25 young people take a deep dive into research on rare diseases and immunology at the Life Science Learning Lab “Gläsernes Labor,” including by ana...
more ...Kirstin Bodensiek appointed Administrative Director
As of August 15, 2026, Kirstin Bodensiek has officially taken the helm as Administrative Director of the Max Delbrück Center. She is stepping into the permanent position after leading the center on an...
more ...Eckert & Ziegler Remains on Track in the First Half of 2026
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) reported sales of €149.3 million in the first half of 2026. The group’s adjusted EBIT dropped by just under 6% to €33.3 million. Adjusted EBIT in the Me...
more ...Events Buch Berlin
10.09.2026, 18:00
Lesebühnenherbst im Stadtgut Berlin-Buch
mit Paul Bokoswki und Kirsten Fuchs
more ...11.09.2026, 18:30
Wie verändert Stammzellforschung die Medizin von morgen? Diabetes, Muskelerkrankungen, Organoide
Könnten Stammzellen eines Tages Menschen mit Diabetes helfen? Welche neuen Perspektiven gibt es bei Muskelerkrankungen? Und warum spielen sogenannte Organoide – kleine Organmodelle aus dem Labor – ein...
more ...12.09.2026, 11:00
Tag des offenen Denkmals
Im Erdgeschoss des Oskar-und-Cécile-Vogt-Hauses sind wissenschaftliche Geräte aus einem Jahrhundert biomedizinischer Forschung ausgestellt, die Etappen der Medizin- und Forschungsgeschichte nachzeichn...
more ...